Effect of Sertraline on Cardiovascular Events and Restenosis after Coronary Stenting in Depression Patients with Acute Coronary Syndrome

刘新兵,周明成,吴敏生,黄红漫,冯六六,俞建华,许其倓,曹国良,葛均波
DOI: https://doi.org/10.3969/j.issn.1674-3474.2007.07.011
2007-01-01
Abstract:Objective To investigate the clinical effects of sertraline on cardiovascular events and restenosis after coronary stenting in depression patients with acute coronary syndrome.Methods Depression patients with acute coronary syndromes reffered for coronary stenting were randomly divided into two groups,in which one group received oral sertraline and base therapy(therapy group),and the other received base therapy only (control group). The cardiovascular events(angina pectoris, myocardia infarction, congestive heart failure and death) and stenting restenosis were carefully observed for 1 year. Results (1)Baseline patametres had no statistic difference between two groups(P0.05). (2)Cardiovascular events after coronary stenting were significantly lower in therapy group than control group (13.7.8%vs 30.2%), but restenosis had no statistic difference between therapy group and control group (11.8% vs 17.0%). Conclusion Sertraline can decrease cardiovascular events after coronary stenting in depression patients with acute coronary syndrome but no difference on stenting restenosis.
What problem does this paper attempt to address?